Stay updated on Daratumumab in AL Amyloidosis Clinical Trial
Sign up to get notified when there's something new on the Daratumumab in AL Amyloidosis Clinical Trial page.

Latest updates to the Daratumumab in AL Amyloidosis Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe revision tag on the page was updated from v3.6.2 to v3.6.3, indicating a new build of the page. This update reflects a minor change to the page's software rather than its content.SummaryDifference0.0%

- Check17 days agoChange DetectedFooter now displays Revision: v3.6.2, replacing the previous v3.6.0. This indicates a small build/version update for the page rather than changes to study details or available actions.SummaryDifference0.0%

- Check31 days agoChange DetectedThe page now marks recruitment as closed, indicating that no new participants will be enrolled.SummaryDifference0.2%

- Check38 days agoChange Detected**Revision tag updated**: The page now displays Revision: v3.5.5, replacing v3.5.4. This signals a new build of the page and may include minor fixes or updates, while the study details remain unchanged.SummaryDifference0.0%

- Check60 days agoChange DetectedA new Blood publication citation for ANDROMEDA survival analysis was added to the Publications section, and the page revision history shows an update to v3.5.4 from v3.5.3.SummaryDifference0.0%

- Check82 days agoChange DetectedThe ClinicalTrials.gov page’s displayed revision/version number was updated from v3.5.0 to v3.5.3.SummaryDifference0.0%

Stay in the know with updates to Daratumumab in AL Amyloidosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab in AL Amyloidosis Clinical Trial page.